Astra Report issue

Contributed to NME For profit Phase 1 Phase 4
Founded: Sodertalje Sweden (1913)
Status: Acquired by AstraZeneca (1999)

Organization Overview

First Clinical Trial
1999
NCT00002125
First Marketed Drug
1965
prilocaine (citanest)
First NDA Approval
1965
prilocaine (citanest)
Last Known Activity
1999

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Astra USA

Active Ingredients

Marketed Drugs (9)

candesartan (atacand) (NDA)

dyclonine (sucrets) (NDA)

etidocaine (duranest) (NDA)

lidocaine (xylocaine) (NDA)

omeprazole (prilosec) (1989 NDA)

prilocaine (citanest) (1965 NDA)

ritodrine (yutopar) (1980 NDA)

tocainide (tonocard) (1984)

zimeldine (Normud) (NDA)

Drugs in Phase 4 Trials (2)

foscarnet (foscavir) (10 trials)

magnesium sulfate (Tis-U-Sol) (1 trial)

Drugs in Phase 1 Trials (1)

ganciclovir (cytovene) (1 trial)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 3